| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 40.675 | 382.303 | 3.523.587 | 5.083.229 | 2.012.078 | 789.897 | 1.065.444 |
| Total Income - EUR | - | - | - | 40.675 | 408.794 | 3.604.397 | 5.140.938 | 2.103.584 | 793.575 | 1.065.977 |
| Total Expenses - EUR | - | - | - | 50.864 | 434.043 | 3.224.226 | 4.747.281 | 2.048.029 | 879.076 | 1.069.551 |
| Gross Profit/Loss - EUR | - | - | - | -10.189 | -25.249 | 380.171 | 393.657 | 55.555 | -85.501 | -3.575 |
| Net Profit/Loss - EUR | - | - | - | -10.596 | -29.337 | 326.485 | 329.210 | 46.021 | -85.501 | -3.575 |
| Employees | - | - | - | 1 | 5 | 6 | 9 | 10 | 10 | 9 |
Check the financial reports for the company - Poftim Farmagrup S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 43.039 | 27.084 | 41.538 | 46.533 | 78.878 | 56.953 | 35.201 |
| Current Assets | - | - | - | 47.112 | 189.721 | 407.952 | 698.010 | 706.158 | 807.022 | 881.533 |
| Inventories | - | - | - | 24.533 | 67.762 | 198.774 | 186.319 | 63.822 | 100.560 | 88.929 |
| Receivables | - | - | - | 11.928 | 115.477 | 187.689 | 437.179 | 608.668 | 674.375 | 750.120 |
| Cash | - | - | - | 10.651 | 6.482 | 21.488 | 74.513 | 33.668 | 32.088 | 42.483 |
| Shareholders Funds | - | - | - | -10.553 | -39.685 | 287.552 | 610.386 | 658.300 | 570.803 | 564.038 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 100.713 | 256.525 | 162.001 | 134.258 | 126.845 | 293.394 | 352.842 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Poftim Farmagrup S.r.l.